SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001104659-14-010671
Filing Date
2014-02-14
Accepted
2014-02-14 16:39:32
Documents
1
Group Members
JOHN G. FREUNDSKYLINE VENTURE MANAGEMENT V, LLCSTEPHEN HOFFMAN, M.D., PH.D.YASUNORI KANEKO

Document Format Files

Seq Description Document Type Size
1 SC 13D a14-5855_3sc13d.htm SC 13D 178568
  Complete submission text file 0001104659-14-010671.txt   180188
Mailing Address 480 ARSENAL ST. BUILDING 1, SUITE 120 WATERTOWN MA 02472
Business Address 480 ARSENAL ST. BUILDING 1, SUITE 120 WATERTOWN MA 02472 617 621 8097
Dicerna Pharmaceuticals Inc (Subject) CIK: 0001399529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-87866 | Film No.: 14617651
SIC: 2834 Pharmaceutical Preparations

Mailing Address 525 University Avenue Suite 520 Palo Alto CA 94301
Business Address 525 University Avenue Suite 520 Palo Alto CA 94301
Skyline Venture Partners V LP (Filed by) CIK: 0001419187 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13D